- Home
- MLP vs CMPX Comparison
MLP vs CMPX Comparison
Compare MLP & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- CMPX
- Stock Information
- Founded
- MLP 1909
- CMPX 2014
- Country
- MLP United States
- CMPX United States
- Employees
- MLP N/A
- CMPX N/A
- Industry
- MLP Real Estate
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- MLP Finance
- CMPX Health Care
- Exchange
- MLP Nasdaq
- CMPX Nasdaq
- Market Cap
- MLP 344.7M
- CMPX 291.8M
- IPO Year
- MLP 1972
- CMPX N/A
- Fundamental
- Price
- MLP $16.19
- CMPX $3.05
- Analyst Decision
- MLP
- CMPX Strong Buy
- Analyst Count
- MLP 0
- CMPX 9
- Target Price
- MLP N/A
- CMPX $12.67
- AVG Volume (30 Days)
- MLP 11.8K
- CMPX 727.6K
- Earning Date
- MLP 08-18-2025
- CMPX 08-11-2025
- Dividend Yield
- MLP N/A
- CMPX N/A
- EPS Growth
- MLP N/A
- CMPX N/A
- EPS
- MLP N/A
- CMPX N/A
- Revenue
- MLP $14,886,000.00
- CMPX $850,000.00
- Revenue This Year
- MLP N/A
- CMPX N/A
- Revenue Next Year
- MLP N/A
- CMPX N/A
- P/E Ratio
- MLP N/A
- CMPX N/A
- Revenue Growth
- MLP 57.13
- CMPX N/A
- 52 Week Low
- MLP $14.05
- CMPX $0.87
- 52 Week High
- MLP $26.46
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- MLP 40.20
- CMPX 56.85
- Support Level
- MLP $16.86
- CMPX $3.11
- Resistance Level
- MLP $18.25
- CMPX $3.26
- Average True Range (ATR)
- MLP 0.77
- CMPX 0.21
- MACD
- MLP -0.16
- CMPX -0.01
- Stochastic Oscillator
- MLP 8.00
- CMPX 50.92
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.